公开(公告)号：US4501738A

公开(公告)日：1985-02-26

申请号：US620923

申请日：1984-06-15

申请人： Hideyuki Yamato ,  Yuji Maeda ,  Fumisato Yoshino ,  Kyoya Takahata ,  Masanori Ikuzawa ,  Tadaaki Kato ,  Chikao Yoshikumi

发明人： Hideyuki Yamato ,  Yuji Maeda ,  Fumisato Yoshino ,  Kyoya Takahata ,  Masanori Ikuzawa ,  Tadaaki Kato ,  Chikao Yoshikumi

IPC分类号： A61K31/59

CPC分类号： A61K31/59

摘要： Disclosed is a pharmaceutical composition in dosage unit form which comprises a dosage effective for the treatment of pains and pyrexia, hypertension, hypotension, hyperlipemia, inflammatory diseases or diseases due to the functional accentuation of thrombocytes of a compound of 24,25-dihydroxycholecalciferol and a pharmaceutical acceptable carrier or diluent therefor.

摘要翻译： 公开了一种剂量单位形式的药物组合物，其包含有效治疗疼痛和发热，高血压，低血压，高脂血症，炎性疾病或由于二羟基胆钙化甾醇化合物的血小板功能强化引起的疾病的剂量 药用载体或稀释剂。

公开(公告)号：US4534975A

公开(公告)日：1985-08-13

申请号：US656760

申请日：1984-10-01

申请人： Hideyuki Yamato ,  Yuji Maeda ,  Fumisato Yoshino ,  Kyoya Takahata ,  Masanori Ikuzawa ,  Tadaaki Kato ,  Chikao Yoshikumi

发明人： Hideyuki Yamato ,  Yuji Maeda ,  Fumisato Yoshino ,  Kyoya Takahata ,  Masanori Ikuzawa ,  Tadaaki Kato ,  Chikao Yoshikumi

IPC分类号： A61K31/59

CPC分类号： A61K31/59

摘要： Disclosed is a pharmaceutical composition in dosage unit form which comprises a dosage effective for the treatment of pains and pyrexia, hypertension, hypotension, hyperlipemia, inflammatory diseases or diseases due to the functional accentuation of thrombocytes of a compound of 24,25-dihydroxycholecalciferol and a pharmaceutical acceptable carrier or diluent therefor.

摘要翻译： 公开了一种剂量单位形式的药物组合物，其包含有效治疗疼痛和发热，高血压，低血压，高脂血症，炎性疾病或由于二羟基胆钙化甾醇化合物的血小板功能强化引起的疾病的剂量 药用载体或稀释剂。

公开(公告)号：US07034058B2

公开(公告)日：2006-04-25

申请号：US10634641

申请日：2003-08-04

申请人： Kyoya Takahata

发明人： Kyoya Takahata

IPC分类号： A61K31/16

CPC分类号： A61K31/165

摘要： The present invention provides an anti-tumor pharmaceutical composition having a high anti-tumor effect with low side-effects. The anti-tumor pharmaceutical composition comprises a N-vanillyl fatty acid amide of formula (1): wherein —CO—R group represents a saturated or unsaturated fatty acid residue containing from 14 to 32 carbon atoms. Accordingly the invention provides an anti-tumor pharmaceutical composition comprising a N-vanillyl fatty acid amide which relates to capsaicin wherein the composition has a low side-effect and a high anti-tumor effect, in particular an anti-melanoma effect and an anti-leukemia cell effect; and is very low pungent, stimulatory and preinflammatory effect.

摘要翻译： 本发明提供具有高抗肿瘤效果和低副作用的抗肿瘤药物组合物。 抗肿瘤药物组合物包含式（1）的N-香草基脂肪酰胺：其中-CO-R基团表示含有14至32个碳原子的饱和或不饱和脂肪酸残基。 因此，本发明提供了包含N-香草基脂肪酸酰胺的抗肿瘤药物组合物，其涉及辣椒素，其中所述组合物具有低副作用和高抗肿瘤作用，特别是抗黑素瘤作用， 白血病细胞效应; 且刺激性和炎症前期刺激性极低。

公开(公告)号：US06713093B2

公开(公告)日：2004-03-30

申请号：US10118076

申请日：2002-04-09

申请人： Kyoya Takahata ,  Yokichi Matsui

发明人： Kyoya Takahata ,  Yokichi Matsui

IPC分类号： A01N6500

CPC分类号： A61Q7/00 ,  A23F3/163 ,  A23F3/32 ,  A61K8/97

摘要： The present invention provides an antialopecia agent which is a drug for protecting, reducing or preventing alopecia frequently occurring as the side effect of anticancer agents, wherein the drug inflicts neither any pain nor unpleasantness on patients under the treatment with anticancer agents and has a high safety; and foods or beverages containing this antialopecia agent. The antialopecia agent of the present invention is characterized by containing oolong tea extract as the active ingredient.

摘要翻译： 本发明提供了作为抗癌剂的副作用而经常发生的脱发的药物的抗真菌药，其中药物对抗癌剂治疗的患者既不施加任何疼痛也不令人不快，安全性高 ; 以及含有该抗真菌药物的食品或饮料。 本发明的抗真菌药物的特征在于含有乌龙茶提取物作为活性成分。